FDA would like to cut back on the amount of time staffers have to spend poring over millions of adverse event case reports. To that end, the agency is looking for academic institutions or commercial organizations with technology that can run an automated analysis of the data.
FDA posted
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?